KENILWORTH, NJ — A new drug, Lynparza (olaparib) has been approved for pancreatic cancer patients in the United States whose diseases have not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen, a report from Fox 2...
News, views and interviews from the Arab world and the Arab American community.
error: Content is protected !!
We depend on you to keep our unwavering level of independence and maintain our mission. Will you support us? Unlike many news organizations, we made a choice to keep all of our independent, investigative reporting free and available for everyone in our community.Please support The Arab American News today.